Recipe for perfect balance of breaks and repairs in our genome could help fight cancer

June 12, 2018, University of Sheffield
Credit: CC0 Public Domain

Scientists at the University of Sheffield have discovered what keeps the perfect balance of breaks and repairs in our DNA—something which could help improve the success of chemotherapy and combat neurodegeneration associated with ageing.

Our genome, where precious genetic information is stored, is challenged with thousands of breaks every day.

Cells possess an army of proteins that search for, detect and fix these breaks to maintain genome integrity, but little is known about how the cell fine-tunes the level of response in these factories to suit each and every repair event.

The level of proteins in our is controlled by synthesis and degradation. Cells get rid of proteins when not needed by attaching a small peptide called ubiquitin.

The new study, led by Dr. Sherif El-Khamisy at the University of Sheffield's Department of Molecular Biology and Biotechnology, has revealed an enzyme called UCHL3, which controls DNA repair by removing ubiquitin marks from TDP1—a DNA repair protein. The findings also have implications in brain ageing which has an affect on memory, cognitive function and learning.

An overexpression of UCHL3 causes less ubiquitination of TDP1 and increases its level, which is found in chemotherapy resistant cancers such as rhabdosarcoma—the most common in children, which has a debilitating effect on the muscles, tendons and cartilage.

Too little UCHL3, however, was found to cause more ubiquitination of TDP1 reducing its level in such as ataxias—a group of disorders that affect co-ordination, balance and speech.

Dr. El-Khamisy said: "This study identifies UCHL3 as a novel therapeutically druggable target where suppression of its activity can improve cancer treatment, whereas encouraging and fuelling its activity can combat neurodegeneration.

"Defective DNA repair is a common theme in a number of neurological disorders including and dementia. Finding novel approaches to fuel the cell's ability to repair genomic breaks may hold promise in improving treatment of a broad range of neurological diseases."

The five-year study is funded by a Wellcome Trust Investigator Award to Dr. El-Khamisy and involved collaborations across departments at The University of Sheffield and internationally.

The full study is published today (12 June 2018) in the journal Cell Reports.

Explore further: Enzyme that regulates DNA repair may offer new precision treatments for breast and ovarian cancer

Related Stories

Enzyme that regulates DNA repair may offer new precision treatments for breast and ovarian cancer

December 12, 2016
Researchers at Mayo Clinic have identified an enzyme called UCHL3 that regulates the BRCA2 pathway, which is important for DNA repair. Results of this research are published online in Genes & Development.

Unraveling the mystery of DNA attacks in cells' powerhouse could pave way for new cancer treatments

April 28, 2017
New research has unravelled the mystery of how mitochondria—the energy generators within cells—can withstand attacks on their DNA from rogue molecules.

New discovery in motor neuron disease and dementia could pave the way to novel treatments

July 17, 2017
New discovery in motor neurone disease and dementia could pave the way to novel treatments

New discovery in understanding chemotherapy resistance could prevent cancer cells fighting back

October 28, 2016
Scientists have made an important breakthrough in understanding why some cancer cells become resistant to chemotherapy.

New research uncovers 'stability protein' for cancer treatment

May 4, 2018
Researchers from the Novo Nordisk Foundation Center for Protein Research at the Faculty of Health and Medical Sciences have characterised a new protein that is important to the genetic stability of cells. It may be significant ...

New study unravels mystery of a DNA repair process

March 14, 2012
(Medical Xpress) -- Scientists at the University of Sussex have uncovered the mechanism of a key process in DNA repair that helps prevent neurodegenerative diseases such as ataxia.

Recommended for you

Critical role of DHA on foetal brain development revealed

August 17, 2018
Duke-NUS researchers have found evidence that a natural form of Docosahexaenoic Acid (DHA) made by the liver called Lyso-Phosphatidyl-Choline (LPC-DHA), is critical for normal foetal and infant brain development, and that ...

New algorithm could improve diagnosis of rare diseases

August 17, 2018
Today, diagnosing rare genetic diseases requires a slow process of educated guesswork. Gill Bejerano, Ph.D., associate professor of developmental biology and of computer science at Stanford, is working to speed it up.

Gene silencing critical for normal breast development

August 17, 2018
Researchers have discovered that normal breast development relies on a genetic 'brake', a protein complex that keeps swathes of genes silenced.

Officials remove special rules for gene therapy experiments

August 16, 2018
U.S. health officials are eliminating special regulations for gene therapy experiments, saying that what was once exotic science is quickly becoming an established form of medical care with no extraordinary risks.

Genetic link discovered between circadian rhythms and mood disorders

August 15, 2018
Circadian rhythms are regular 24-hour variations in behaviour and activity that control many aspects of our lives, from hormone levels to sleeping and eating habits.

Ovarian cancer genetics unravelled

August 14, 2018
Patterns of genetic mutation in ovarian cancer are helping make sense of the disease, and could be used to personalise treatment in future.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.